NO881709L - Fremgangsmaate ved fremstilling av nye dihydropyridinderivater. - Google Patents

Fremgangsmaate ved fremstilling av nye dihydropyridinderivater.

Info

Publication number
NO881709L
NO881709L NO881709A NO881709A NO881709L NO 881709 L NO881709 L NO 881709L NO 881709 A NO881709 A NO 881709A NO 881709 A NO881709 A NO 881709A NO 881709 L NO881709 L NO 881709L
Authority
NO
Norway
Prior art keywords
formula
compound
alkyl
methyl
mixture
Prior art date
Application number
NO881709A
Other languages
English (en)
Norwegian (no)
Other versions
NO881709D0 (no
Inventor
David Alker
Peter Edward Cross
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of NO881709D0 publication Critical patent/NO881709D0/no
Publication of NO881709L publication Critical patent/NO881709L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
NO881709A 1987-04-21 1988-04-20 Fremgangsmaate ved fremstilling av nye dihydropyridinderivater. NO881709L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878709447A GB8709447D0 (en) 1987-04-21 1987-04-21 Dihydropyridines

Publications (2)

Publication Number Publication Date
NO881709D0 NO881709D0 (no) 1988-04-20
NO881709L true NO881709L (no) 1988-10-24

Family

ID=10616115

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881709A NO881709L (no) 1987-04-21 1988-04-20 Fremgangsmaate ved fremstilling av nye dihydropyridinderivater.

Country Status (19)

Country Link
US (1) US4957930A (cs)
EP (1) EP0295769A3 (cs)
JP (1) JPS63280062A (cs)
KR (1) KR880012554A (cs)
CN (1) CN88102381A (cs)
AU (1) AU592498B2 (cs)
CS (1) CS270242B2 (cs)
DD (1) DD273437A5 (cs)
DK (1) DK213988A (cs)
FI (1) FI881824A7 (cs)
GB (1) GB8709447D0 (cs)
HU (1) HUT46894A (cs)
IL (1) IL86108A0 (cs)
NO (1) NO881709L (cs)
NZ (1) NZ224298A (cs)
PL (1) PL271920A1 (cs)
PT (1) PT87272A (cs)
YU (1) YU78388A (cs)
ZA (1) ZA882765B (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2014089C (en) * 1989-07-21 1997-01-14 Vernon L. Lamb Apparatus and method for making pressboard from poly-coated paper using relative movement of facing webs
CN103274993A (zh) * 2013-06-13 2013-09-04 南京工业大学 二氢吡啶和吡咯类杂环的新合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
JPS60120861A (ja) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体
GB8412208D0 (en) * 1984-05-12 1984-06-20 Pfizer Ltd Quinolone inotropic agents
EP0200524A3 (en) * 1985-05-03 1987-06-16 Pfizer Limited Dihydropyridine calcium antagonists

Also Published As

Publication number Publication date
AU1478788A (en) 1988-10-27
US4957930A (en) 1990-09-18
PL271920A1 (en) 1989-03-20
NO881709D0 (no) 1988-04-20
ZA882765B (en) 1989-12-27
KR880012554A (ko) 1988-11-28
DK213988D0 (da) 1988-04-20
DD273437A5 (de) 1989-11-15
FI881824L (fi) 1988-10-22
EP0295769A2 (en) 1988-12-21
NZ224298A (en) 1990-03-27
AU592498B2 (en) 1990-01-11
CS273488A2 (en) 1989-10-13
IL86108A0 (en) 1988-11-15
HUT46894A (en) 1988-12-28
YU78388A (en) 1990-04-30
CN88102381A (zh) 1988-11-09
DK213988A (da) 1988-10-22
FI881824A7 (fi) 1988-10-22
EP0295769A3 (en) 1989-02-08
CS270242B2 (en) 1990-06-13
PT87272A (pt) 1989-05-12
JPS63280062A (ja) 1988-11-17
FI881824A0 (fi) 1988-04-19
GB8709447D0 (en) 1987-05-28

Similar Documents

Publication Publication Date Title
US4430333A (en) Dihydropyridine anti-ischaemic and antihypertensive agents
US4572909A (en) 2-(Secondary aminoalkoxymethyl) dihydropyridine derivatives as anti-ischaemic and antihypertensive agents
FI73992C (fi) Foerfarande foer framstaellning av 4-(3-trifluormetylfenyl-1,2,3,6-tetrahydropyridiner, vilka har anorektisk aktivitet.
FR2511247A1 (fr) Dihydropyridines ayant une action positivement inotrope, leur utilisation comme medicaments et un procede pour leur preparation
NO160259B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive dihydropyridinderivater.
PL140573B1 (en) Method of obtaining new dihydropyridine derivatives
US4652573A (en) Calcium antagonist N-hetero ester 1,4-dihydropyridines
EP0164247B1 (en) Dihydropyridines
EP0257616B1 (en) Dihydropyridine derivates and pharmaceutical composition thereof
EP0161917B1 (en) Dihydropyridines
US5063239A (en) Amino-esters of dihydropyridines useful for improving circulation in patients
NO881709L (no) Fremgangsmaate ved fremstilling av nye dihydropyridinderivater.
NO861756L (no) Fremgangsmaate ved fremstilling av dihydropyridinderivater.
US5064839A (en) 1,4-dihydropyridines with a 2-amino group or with an ether group in a side chain
CA1323876C (en) Dihydropyridine derivatives and pharmaceutical composition thereof
NO893756L (no) Basiske 4-aryl-dhp-amider, fremgangsmaate til deres fremstilling og deres anvendelse i legemidler.
NO173276B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-disubstituerte-piperidinylderivater
EP1266896A1 (fr) Urées linéaires ou cycliques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
IE66677B1 (en) New Diaryl Compounds
JP3987113B2 (ja) 抗高血圧活性を有する新規キナゾリン―４―アミノ―２―（ピペリジン―１―イル―４―置換）誘導体並びにその製造法および医薬用途
NZ267427A (en) Optical isomers of 4(5-fluoro-2,3-dihydro-1h-inden-2-yl)-1h-imidazole, preparation thereof
FR2649395A1 (fr) Nouveau derive de la dihydro-1,4 pyridine denomme (-) Ÿi1Ÿ(((amino-2 ethoxy)-2 ethoxy) methylŸi1Ÿ) -2 (dichloro-2,3 phenyl)-4 ethoxycarbonyl-3 methoxycarbonyl-5 methyl-6 dihydro-1,4 pyridine, son procede de preparation et les compositions qui le contiennent
US4849429A (en) Certain 1,4-dihydro-2,6-dilower-alkyl-4-(mono-substituted pyridyl) useful for treating coronary artery or cerebral artery disease
HU196994B (en) Process for producing pyridine derivatives and pharmaceuticals comprising same
CS249525B2 (cs) Způsob výroby dihydropyridinů